2023 Q2 Form 10-K Financial Statement

#000149315223017485 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $150.9K $1.191M
YoY Change
% of Gross Profit
Research & Development $816.00 $3.280K
YoY Change -6.85% 11.87%
% of Gross Profit
Depreciation & Amortization $250.00 $333.00
YoY Change
% of Gross Profit
Operating Expenses $151.0K $1.192M
YoY Change 5.82% 127.17%
Operating Profit -$1.192M
YoY Change 127.17%
Interest Expense -$6.530K -$20.61K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$151.0K -$1.192M
YoY Change 5.82% 127.17%
Income Tax
% Of Pretax Income
Net Earnings -$157.6K -$1.212M
YoY Change 10.4% 279.01%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 131.9M shares 131.9M shares 105.9M shares
Diluted Shares Outstanding 131.9M shares 105.9M shares

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $4.650K $1.090K
YoY Change
Inventory
Prepaid Expenses $4.647K $1.094K
Receivables
Other Receivables
Total Short-Term Assets $4.647K $1.094K $1.090K
YoY Change -21.36% -74.12%
LONG-TERM ASSETS
Property, Plant & Equipment $917.00 $1.167K $1.170K
YoY Change -35.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $917.00 $1.167K $1.170K
YoY Change -89.38% -83.84%
TOTAL ASSETS
Total Short-Term Assets $4.647K $1.094K $1.090K
Total Long-Term Assets $917.00 $1.167K $1.170K
Total Assets $5.564K $2.261K $2.260K
YoY Change -61.75% -80.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.39K $37.70K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.581M $1.275M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.581M $1.275M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.581M $1.275M $1.275M
YoY Change -60.21% -65.37%
SHAREHOLDERS EQUITY
Retained Earnings -$11.58M -$11.27M
YoY Change 12.49% 12.7%
Common Stock $132.00 $129.00
YoY Change 55.29% 51.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.575M -$1.273M -$1.273M
YoY Change
Total Liabilities & Shareholders Equity $5.564K $2.261K $2.260K
YoY Change -61.75% -80.25%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$157.6K -$1.212M
YoY Change 10.4% 279.01%
Depreciation, Depletion And Amortization $250.00 $333.00
YoY Change
Cash From Operating Activities $0.00 -$561.6K
YoY Change 6.27%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.500K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$1.500K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $558.9K
YoY Change 5.85%
NET CHANGE
Cash From Operating Activities 0.000 -$561.6K
Cash From Investing Activities 0.000 -$1.500K
Cash From Financing Activities $558.9K
Net Change In Cash 0.000 -$4.227K
YoY Change 766.19%
FREE CASH FLOW
Cash From Operating Activities $0.00 -$561.6K
Capital Expenditures $0.00 $1.500K
Free Cash Flow $0.00 -$563.1K
YoY Change 6.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Gross Profit
GrossProfit
usd
CY2021 us-gaap Gross Profit
GrossProfit
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001487091
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2022 QWTR Consulting Fees
ConsultingFees
usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022 QWTR Reversal Of Accounts Payable
ReversalOfAccountsPayable
usd
CY2022 QWTR Forgiveness Of Debt
ForgivenessOfDebt
usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2021 us-gaap Depreciation
Depreciation
usd
CY2022 QWTR Reversal Of Accounts Payable
ReversalOfAccountsPayable
usd
CY2022 QWTR Forgiveness Of Debt
ForgivenessOfDebt
usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2022 QWTR Increase Decrease In Unbilled Costs
IncreaseDecreaseInUnbilledCosts
usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021 us-gaap Gross Profit
GrossProfit
usd
CY2021 QWTR Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-168895
CY2022 dei Entity Registrant Name
EntityRegistrantName
QUEST WATER GLOBAL, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1994359
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 209 – 828 Harbourside Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
North Vancouver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V7P 3R9
CY2022 dei City Area Code
CityAreaCode
888
CY2022 dei Local Phone Number
LocalPhoneNumber
897-5536
CY2022 dei Security12g Title
Security12gTitle
Common stock, $0.000001 par value
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
4980031.73 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131903029 shares
CY2022 dei Auditor Firm
AuditorFirmId
1212
CY2022 dei Auditor Name
AuditorName
K. R. MARGETSON LTD
CY2022 dei Auditor Location
AuditorLocation
North Vancouver BC
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4227 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1094 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1094 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4227 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2022Q4 us-gaap Assets
Assets
2261 usd
CY2021Q4 us-gaap Assets
Assets
4227 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37698 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15100 usd
CY2022Q4 QWTR Due To Related Company Current
DueToRelatedCompanyCurrent
49841 usd
CY2021Q4 QWTR Due To Related Company Current
DueToRelatedCompanyCurrent
71200 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1153613 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3632758 usd
CY2022Q4 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
33980 usd
CY2021Q4 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
13367 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1275132 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3732425 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021 QWTR Forgiveness Of Debt
ForgivenessOfDebt
175000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85164569 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85164569 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
129 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
85 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000351 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6332748 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11273352 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10061032 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3728198 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2261 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4227 usd
CY2022 QWTR Automotive Expenses
AutomotiveExpenses
10050 usd
CY2021 QWTR Automotive Expenses
AutomotiveExpenses
8824 usd
CY2021 QWTR Consulting Fees
ConsultingFees
771 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
333 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
450000 usd
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
430000 usd
CY2022 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
3491 usd
CY2021 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
7162 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
51874 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
46777 usd
CY2022 QWTR Rent
Rent
21000 usd
CY2021 QWTR Rent
Rent
21000 usd
CY2022 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
3280 usd
CY2021 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
2932 usd
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
22033 usd
CY2021 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
7120 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1191707 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
524586 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1191707 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-524586 usd
CY2022 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20613 usd
CY2021 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20587 usd
CY2021 QWTR Reversal Of Accounts Payable
ReversalOfAccountsPayable
50306 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1212320 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.004
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105908762 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3728198 usd
CY2022Q4 us-gaap Share Price
SharePrice
0.065
CY2022 QWTR Stock Issued During Period Value Shares Issued For Debt
StockIssuedDuringPeriodValueSharesIssuedForDebt
3038000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1212320 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3408331 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3728198 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1212320 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2022 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20613 usd
CY2021 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20587 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Depreciation
Depreciation
333 usd
CY2021 QWTR Reversal Of Accounts Payable
ReversalOfAccountsPayable
50306 usd
CY2021 QWTR Forgiveness Of Debt
ForgivenessOfDebt
175000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1094 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22598 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3815 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-21359 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-112764 usd
CY2021 QWTR Increase Decrease In Unbilled Costs
IncreaseDecreaseInUnbilledCosts
-112724 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-561582 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-528441 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1500 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
558855 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
527953 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
558855 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
527953 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4227 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-488 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4715 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2022Q4 QWTR Working Capital Deficiency
WorkingCapitalDeficiency
1274038 usd
CY2022Q4 QWTR Liability To Principal Stockholders Due To Working Capital Deficiency
LiabilityToPrincipalStockholdersDueToWorkingCapitalDeficiency
1153613 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11273352 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zXGiSxgBFkE8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zA78pmLrLGLe">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6300000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.10
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zvZmbJMKSxq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zOIHBmS1i7zf">Correction of an error in previously issued financial statement</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows ASC Topic 250, <i>Accounting changes and error corrections </i>when accounting for accounting changes and errors in previously issued financial statements. The former is a change in accounting principle, accounting estimates, or in reporting entity. The latter is an error in recognition, measurement, presentation or disclosure in financial statements arising from mathematical mistakes, mistakes in the application of generally accepted accounting principles or oversight or misuse of facts that existed at the time the financial statements were prepared. This guidance requires retroactive application unless it is impractical to do so, in which case reasons for the impracticality must be stated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2200000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6300000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1500 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
333 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.065
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.065
CY2022 QWTR Issued And Outstanding Common Stock Percentage
IssuedAndOutstandingCommonStockPercentage
0.10 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.10
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
629647 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2200000 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.0667 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0317 pure
CY2021Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
50206 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
-13367 usd
CY2021Q4 QWTR Due To Related Company Current
DueToRelatedCompanyCurrent
71200 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10061032 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-524586 usd
CY2021 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20587 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-319867 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2021 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
20587 usd
CY2021 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-112764 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1212320 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-319867 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
255000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
67000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
30000 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
24000 usd
CY2022 QWTR Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
137000 usd
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-15000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
148000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
106000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1304000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1156000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1304000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1156000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
R41.htm Edgar Link pending
0001493152-23-017485-index-headers.html Edgar Link pending
0001493152-23-017485-index.html Edgar Link pending
0001493152-23-017485.txt Edgar Link pending
0001493152-23-017485-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qwtr-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
qwtr-20221231_cal.xml Edgar Link unprocessable
qwtr-20221231_def.xml Edgar Link unprocessable
qwtr-20221231_lab.xml Edgar Link unprocessable
qwtr-20221231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending